Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors (Q39899613)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors |
scientific article |
Statements
1 reference
Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors (English)
1 reference
Angela Coxon
1 reference
Tammy Bush
1 reference
Douglas Saffran
1 reference
Stephen Kaufman
1 reference
Brian Belmontes
1 reference
Karen Rex
1 reference
Paul Hughes
1 reference
Sean Caenepeel
1 reference
James B Rottman
1 reference
Andrew Tasker
1 reference
Vinod Patel
1 reference
Richard Kendall
1 reference
Robert Radinsky
1 reference
Anthony Polverino
1 reference
1 January 2009
1 reference
1 reference
Identifiers
1 reference